Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01255059 | GWAS Research of Lung Cancer in Tianjin | unknown | — | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01660399 | Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy | unknown | Phase 2 | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 |
| clinicaltrials |
| NCT02631460 | S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC | unknown | Phase 2 | 470 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT01494415 | Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer | unknown | Phase 2 | 21 | First People's Hospital of HangzhouOTHER | 1 | Dec 15, 2015 | clinicaltrials |
| NCT01891123 | Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy | unknown | N/A | 300 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT02445872 | Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy | unknown | Phase 2 | 80 | Zhejiang UniversityOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT02603627 | Prevalence of COPD in Our Lung Cancer Population, Compared to Controls | unknown | — | 200 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Nov 13, 2015 | clinicaltrials |
| NCT02273271 | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo(EVIDENCE) | unknown | N/A | 31 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Oct 30, 2015 | clinicaltrials |
| NCT02584699 | Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC | unknown | Phase 2 | 40 | Luhua WangUNKNOWN | 1 | Oct 23, 2015 | clinicaltrials |
| NCT02395939 | Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL(CT-CROP) | unknown | Phase 3 | 158 | Middlemore Hospital, New ZealandOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT02555592 | Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level | unknown | — | 25 | Pusan National University HospitalOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT02549261 | Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer | unknown | N/A | 150 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT01646450 | First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients | unknown | Phase 4 | 35 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01707329 | Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02540824 | Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT02321293 | A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC(CURCUMIN) | unknown | Phase 1 | 20 | Lady Davis InstituteOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02535507 | Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 28, 2015 | clinicaltrials |
| NCT01914120 | the Quality of Life Assessment of Lung Cancer Patients in China | unknown | — | 3,000 | Sun Yat-sen UniversityOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT02283021 | Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC) | unknown | — | 200 | Hadassah Medical OrganizationOTHER | 0 | Aug 20, 2015 | clinicaltrials |
| NCT01592617 | Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer | unknown | Phase 2 | 45 | Shiga UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02513355 | Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research | unknown | Phase 4 | 400 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 4, 2015 | clinicaltrials |
| NCT01998425 | Circulating Fibrocytes in Non-small Cell Lung Cancer. | unknown | — | 60 | Chang Gung Memorial HospitalOTHER | 1 | Jul 31, 2015 | clinicaltrials |
| NCT02504801 | Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD | unknown | Phase 4 | 73 | Xiuyi ZhiOTHER | 0 | Jul 22, 2015 | clinicaltrials |
| NCT01843647 | Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients | unknown | Phase 2 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT01926171 | Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases | unknown | Phase 4 | 80 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02062515 | Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02497586 | Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer(MRS) | unknown | N/A | 15 | NHS Greater Glasgow and ClydeOTHER | 0 | Jul 14, 2015 | clinicaltrials |
| NCT02006043 | Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) | unknown | Phase 2 | 54 | Li ZhangOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT02481661 | Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC | unknown | Phase 3 | 610 | Zhejiang Cancer HospitalOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT01172925 | Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer(TIDAL) | unknown | Phase 2 | 34 | Hamilton Health Sciences CorporationOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01929200 | Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02027090 | High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease | unknown | Phase 2 | 64 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02437760 | The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring | unknown | — | 200 | E-DA HospitalOTHER | 1 | May 8, 2015 | clinicaltrials |
| NCT02132143 | Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 | unknown | N/A | 60 | Hui LinOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02430974 | Chemotherapy of NSCLC With or Without Icotinib | unknown | Phase 2 | 50 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2015 | clinicaltrials |
| NCT02155426 | Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy | unknown | — | 1,200 | Sun Yat-sen UniversityOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT01914263 | Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection | unknown | Phase 1 | 40 | Alliancells-PuRui Biocience Co., Ltd.INDUSTRY | 1 | Apr 16, 2015 | clinicaltrials |
| NCT01772732 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC | unknown | Phase 1 | 30 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 9, 2015 | clinicaltrials |
| NCT02407600 | Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy | unknown | Phase 2 | 150 | Ajeet GajraOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02407366 | Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 80 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Apr 2, 2015 | clinicaltrials |
| NCT02399566 | Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma | unknown | Phase 4 | 300 | Hunan Province Tumor HospitalOTHER | 0 | Mar 26, 2015 | clinicaltrials |
| NCT01549093 | Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 90 | Hunan Province Tumor HospitalOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02375022 | Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations | unknown | Phase 2 | 10 | Zhejiang UniversityOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02066870 | Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI | unknown | Phase 1 | 9 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT02009605 | Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer | unknown | Phase 2 | 30 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02363101 | Health Outcomes and Costs (HOC) in Lung Cancer (LC)(HOC-LC) | unknown | — | 300 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Mar 4, 2015 | clinicaltrials |
| NCT02140333 | Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC | unknown | Phase 3 | 220 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02362204 | Lung Cancer Nurse Model: a Phase II Study(LCN-II) | unknown | — | 71 | University of FreiburgOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02123888 | Simultaneous CBCT Acquisition During Arc Radiotherapy(SCART) | unknown | N/A | 75 | Sally FalkOTHER | 1 | Feb 9, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Dec 22, 2015source: clinicaltrials